Life Molecular Imaging
Manufacturing · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Tegeler Strasse 6-7, Berlin, Berlin, 133...Phone Number
(855) 545-5245Website
www.neuraceq.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Life Molecular Imaging
Life Molecular Imaging specializes in the development of Neuraceq®, a Florbetaben F-18 injection used for diagnosing Alzheimer's disease by targeting beta-amyloid plaques in the brain. Their product is designed for healthcare professionals to assist in evaluating cognitive impairment and determining appropriate treatment pathways. Neuraceq® is indicated for use in adults and is a key component in the diagnostic process for Alzheimer's disease. The company aims to provide essential tools for healthcare providers to enhance patient care in cognitive health.Explore more
Popular SearchesLife Molecular ImagingNeuraceqNeuraceq - PETSIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Life Molecular Imaging your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Life Molecular Imaging
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Life Molecular Imaging has new funding data
Earning: See what the market has to say on Life Molecular Imaging recently announced quarterly report
Click to see if Life Molecular Imaging had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Life Molecular Imaging, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Life Molecular Imaging is spiking on competitors!
Product Launch: Get notified when Life Molecular Imaging launches new products
Check if Life Molecular Imaging has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Life Molecular Imaging
Find more new buyers
Compare Similar Companies to Life Molecular Imaging
Compare insights from companies similar to Life Molecular Imaging, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Life Molecular Imaging
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Life Molecular Imaging is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Life Molecular Imaging is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Life Molecular Imaging.
Life Molecular Imaging Tech Stack
A closer look at the technologies used by Life Molecular Imaging
See more technologies
Life Molecular Imaging News & Media
FDA Expands Indications for Neuraceq®, an Amyloid PET Imaging Agent, to Enhance Diagnosis and Care of Patients with Alzheimer's Disease
New indication added for selection of patients for amyloid-directed therapies Quantitative image analysis added Previous limitations of use removed BOSTON, July 1, 2025 /PRNewswire/ -- Life Molecular Imaging, Ltd. (LMI) announced that the U.S. Food and Drug Administration (FDA) has...Life Molecular Imaging and SOFIE announce Neuraceq® availability in Albany, NY
Improved Neuraceq® supply capabilities to enhance patient access to amyloid PET. BOSTON, May 20, 2025 /PRNewswire/ -- Life Molecular Imaging (LMI), an international pharmaceutical company dedicated to developing and offering novel cutting-edge PET radiopharmaceuticals for imaging, and...Life Molecular Imaging announces Neuraceq® availability at PharmaLogic Salt Lake City
Enhanced the supply capabilities of Neuraceq® to increase patient access to beta-amyloid PET imaging BOSTON, April 24, 2025 /PRNewswire/ -- Life Molecular Imaging (LMI) and PharmaLogic Holdings Corp. (PharmaLogic), a world-class contract development and manufacturing organization (CDMO)...Florbetaben (18F) Injection (Neuraceq®) Set to Launch at St. Teresa's Hospital in Hong Kong in March 2025
Innovative Imaging Solution to Enhance Alzheimer's Disease Diagnosis and Patient Care in the Region BOSTON, March 14, 2025 /PRNewswire/ -- Life Molecular Imaging (LMI) and St. Teresa's Hospital are pleased to announce that Florbetaben (18F) Injection (brand name: Neuraceq®) will be...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Life Molecular Imaging
Sign Up For FreeTo access detailed company insights
Life Molecular Imaging specializes in the development of Neuraceq®, a Florbetaben F-18 injection used for diagnosing Alzheimer's disease by targeting beta-amyloid plaques in the brain. Their product is designed for healthcare professionals to assist in evaluating cognitive impairment and determining appropriate treatment pathways. Neuraceq® is indi... Read More
